placebo

FDA Approves LEQEMBI (lecanemab-irmb) Under the Accelerated Approval Pathway for the Treatment of Alzheimer’s Disease

ruth 9 1 月

13 minutes

TOKYO and CAMBRIDGE, Mass., Ja […]

Eisai Presents Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer’s Disease at Clinical Trials on Alzheimer’s Disease (CTAD) Conference

ruth 30 11 月

3 minutes

TOKYO, Nov 30, 2022 – (J […]

Eisai’s Lecanemab Confirmatory Phase 3 Clarity AD Study Met Primary Endpoint

ruth 28 9 月

6 minutes

TOKYO, Sep 28, 2022 – (J […]

Copyright © 2020 ASEANPR.Com All rights reserved.